BIOECLIPSE THERAPEUTICS
Live / Registered — Registered (as of 06 Apr 2021)
What this means for you
Registered since 06 Apr 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 06 Apr 2027, and its filing window is open now).
Record
- Serial number
- 87398369
- Registration number
- 6315856
- Mark type
- Word mark
- Filed
- 04 Apr 2017
- Published for opposition
- 22 Aug 2017
- Registered
- 06 Apr 2021
- Next maintenance filing
- §8 declaration of use, due by 06 Apr 2027 (grace period to 06 Oct 2027)
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Immunotherapies for the treatment of cancer; pharmaceuticals for the treatment of cancer
Owner
- BIOECLIPSE THERAPEUTICS, INC., MOUNTAIN VIEW, CA, US
- BIOECLIPSE THERAPEUTICS, INC., MOUNTAIN VIEW, CA, US
- ConcentRx, Inc., Milpitas, CA, US
- ConcentRx, Inc., Milpitas, CA, US
Prosecution history
- 06 Apr 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 02 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Feb 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Feb 2021 — ASSIGNED TO LIE
- 13 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Nov 2020 — NON-FINAL ACTION E-MAILED
- 06 Nov 2020 — SU - NON-FINAL ACTION - WRITTEN